(BQ) Part 2 book "Litt's drug eruption reference manual including drug interactions" presents the following contents: Drugs responsible for common reaction patterns, drugs responsible for common reaction patterns, alphabetical index of drug eruptions A–Z
(BQ) Nearly two decades after the first Drug Eruptions & Reactions Manual was compiled by Dr. Litt, this classic work has been developed and expanded into Litt’s D.E.R.M. Relied upon by dermatologists and medical practitioners internationally for its unparalleled practical focus on adverse effects and cutaneous reactions, this text is the essential quick-reference tool for patient care and drug safety.
(BQ) The best and easiest way to learn essential information about the top 300 drugs. Every card includes: Generic and common name, class, dosage forms, approved dose and indications, off-label use, contraindications, adverse reactions, drug interactions,...
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Wertheim cung cấp cho các bạn kiến thức về ngành y đề tài: Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation...
(BQ) Part 2 book "Prescribing at a glance" presentation of content: Logistics of prescribing (How to write a drug prescription, communicating with patients about medicines, therapeutic drug monitoring, avoiding drug interactions,...), specific drug groups (using drugs for the respiratory system, using drugs for the neurological system I, using drugs for infection, an approach to common prescribing requests,...).
Hypertension and Chronic Kidney Disease: Cause and Consequence – Therapeutic Considerations 45 Elsa Morgado and Pedro Leão Neves Potassium-Sparing Diuretics in Hypertension 67 Cristiana Catena, GianLuca Colussi and Leonardo A. Sechi Hypertension and Renin-Angiotensin System Roberto de Barros Silva Pharmacokinetic Interactions of Antihypertensive Drugs with Citrus Juices 95 Yoshihiro Uesawa Drug Interaction
Porous metal organic framework nanoscale carriers as a potential platform for drug
delivery and imaging, In the domain of health, one important challenge is the efficient delivery of drugs in the body using non-toxic nanocarriers. Most of the existing carrier materials show poor drug loading and or rapid release of the proportion of the drug that is simply adsorbed at the external surface of the nanocarrier.
(BQ) Part 2 book "Cardiovascular pharmacotherapeutics" presents the following contents: Alternative and complementarymedicine for preventing and treatingcardiovascular disease, cardiovascular drug–drug interactions, drug treatment of peripheral vascular disorders, cardiovascular drugs in development,...
(BQ) Part 2 book "Cardiovascular pharmacotherapeutics" presentation of content: Cardiovascular Drug–Drug interactions, pediatric cardiovascular pharmacology, drug therapy of cerebrovascular disease, drug treatment of peripheral vascular disorders, cytokines and myocardial regeneration,...
(BQ) Questions to Ask Your Pharmacist - list of questions for patients to ask their pharmacist or healthcare provider when obtaining a new prescription, entries provide information on drug interactions with other drugs, herbs, vitamins, supplements, food, and other substances.
Foreword helps users understand the difference between prescription drugs vs. over-the-counter drugs and also provides other useful information. Narrative sidebars offer users personal examples of drug interactions or adverse side effects to help readers recognize warning signs.
partial charges. When a hydrogen atom bearing a partial positive charge bridges two atoms bearing a partial negative charge, a hydrogen bond is created. A van der Waals’ bond (B) is formed between apolar molecular groups that have come into close proximity. Spontaneous transient distortion of electron clouds (momentary faint dipole, !!) may induce an opposite dipole in the neighboring molecule. The van der Waals’ bond, therefore, is a form of electrostatic attraction, albeit of very low strength (inversely proportional to the seventh power of the distance).
Now in its fifth edition, this best-selling, multidisciplinary textbook continues to draw on the skills of pharmacists and clinicians to present optimal drug regimens. The authors integrate an understanding of the disease processes with an appreciation of pathophysiological processes, clinical pharmacy and the evidence base.
Drug therapy has an effect on the management of patients in
dentistry. Many drugs produce oro-dental problems; in addition
concurrent medication can interact with drugs which the dentist may
prescribe. The aim of this dictionary is to draw together the effects of
drugs on the teeth, oral and perioral structures and highlight drug
interactions which impact on dental treatment. Drugs taken by outpatients
which may be encountered in general dental practice and
interactions with drugs contained in the Dental Practitioners Formulary
have been included.
The synthesis and characterization of chitosan (CS) nanoparticles used as drug carrier was reported. The formation of nanoparticles, taking place in an aqueous phase without using auxiliary toxic substances via the ionic interaction between NH3 + protonated group of CS and phosphate group of sodium tripolyphosphate (TPP) was monitored in situ by combined UV-vis and pH measurements. The synthesized nanoparticles were characterized by TGA/DTA, XRD and TEM. The particle size, estimated by TEM, was found around 50 - 70 nm, with a quite uniform size distribution.
In this communication, we report the synthesis of chitosan (CS, a biodegradable and biocom- patible natural polymer)  nanoparticles as drug carriers by ionic gelation. The method is based on ionic interactions between positively charged groups NH3 + of CS (in dilute CH3COOH solution) and negatively charged of sodium tripolyphos- phate, TPP).
(BQ) Part 1 book "Pharmacology for anaesthesia and intensive care" presents the following contents: Basic principles (Drug passage across the cell membrane, absorption, distribution, metabolism and excretion, drug action,...), core drugs in anaesthetic practice (general anaesthetic agents, aeneral anaesthetic agents, local anaesthetics,...)
(BQ) Part 1 book "Illustrated pharmacology for nurses" presentation of content: Drug development, regulation and management of drug therapy and drug errors, classification and nomenclature of drugs, pharmacodynamics of drugs, pharmacokinetics of drugs,... and other contents.
From the early 1970s to mid-1990s, positron emission tomography (PET)
as a diagnostic imaging modality had been for the most part used in experimental
research. Clinical PET started only a decade ago. 82Rb-RbCl and
18F-Fluorodeoxyglucose were approved by the U.S. Food and Drug administration
in 1989 and 1994, respectively, for clinical PET imaging. Reimbursement
by Medicare was approved in 1995 for 82Rb-PET myocardial
perfusion imaging and for 18F-FDG PET for various oncologic indications
in 1999. Currently several more PET procedures are covered for